DT Form 4: Director RSU vesting and 10b5-1 sale disclosed

Rhea-AI Filing Summary

Dynatrace director Lisa M. Campbell reported the vesting of 2,025 time‑based restricted stock units on 09/04/2025, each convertible into one share of the company’s common stock. On 09/05/2025 she sold 1,013 shares at $49.77 per share pursuant to a Rule 10b5-1 trading plan adopted May 16, 2025. After these transactions she beneficially owns 6,074 shares. The RSUs that vested were part of a grant dated 09/04/2024; 25% vested on 09/04/2025 and the remainder vests quarterly thereafter, subject to continued service.

Positive

• Transparent disclosure of RSU vesting and subsequent sale with specific dates and quantities
• Use of a Rule 10b5-1 trading plan indicates pre‑planned, compliance‑oriented execution of the sale
• Clear vesting schedule stated for RSUs granted 09/04/2024, supporting predictability of future vesting

Negative

• Insider sale of 1,013 shares reduces the director’s immediate ownership
• No information on whether remaining future vesting is subject to performance conditions beyond continued service

Insights

Securities Analyst

TL;DR Routine director RSU vesting and plan‑scheduled sale; transparent compliance with 10b5‑1 rules.

The Form 4 shows a time‑based RSU vesting of 2,025 units and a subsequent sale of 1,013 shares under an established Rule 10b5‑1 plan. This is a standard insider liquidity event rather than a corporate action affecting operations or guidance. The filing provides clear disclosure of the vesting schedule and ownership level, supporting transparency but not conveying new company‑level financial information.

Corporate Governance Expert

TL;DR Evidence of good governance: pre‑arranged trading plan and timely reporting of vested awards.

The reporting indicates adherence to governance best practices: adoption of a 10b5‑1 plan and prompt Form 4 filing signed via power of attorney. The transaction aligns with routine compensation vesting and director liquidity; it does not suggest undisclosed company developments or changes to executive incentives beyond the normal RSU schedule described.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Campbell Lisa M

(Last) (First) (Middle)

C/O DYNATRACE, INC.

280 CONGRESS STREET, 11TH FLOOR

(Street)

BOSTON MA 02210

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Dynatrace, Inc. [ DT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/04/2025		M(1)		2,025	A	(1)	2,025	D
Common Stock	09/05/2025		S(2)		1,013	D	$49.77	1,012	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	09/04/2025		M			2,025	(3)	(1)	Common Stock	2,025	$0	6,074	D

Explanation of Responses:

1. Each time-based restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs do not expire. They either vest or are cancelled prior to the vesting date.

2. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2025.

3. Represents the vesting of RSUs granted on September 4, 2024. 25% of the RSUs granted vested on September 4, 2025 and the balance of the RSUs vest in equal quarterly installments thereafter until fully vested, subject to the Reporting Person's continued service as director of the Issuer on the applicable vesting dates.

Remarks:

	/s/ Marc Gold, by power of attorney	09/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Dynatrace director Lisa M. Campbell report on Form 4 (DT)?

She reported the vesting of 2,025 RSUs on 09/04/2025 and a sale of 1,013 shares on 09/05/2025 at $49.77 per share.

Was the sale by the director pre‑planned under a trading plan?

Yes. The sale was executed pursuant to a Rule 10b5‑1 trading plan adopted on May 16, 2025.

How many shares does the reporting person beneficially own after the transactions?

The filing shows beneficial ownership of 6,074 shares following the reported transactions.

When do the remaining RSUs vest for the grant referenced?

25% vested on 09/04/2025; the balance vests in equal quarterly installments thereafter, subject to continued service as a director.

What was the grant date for the RSUs that vested?

The RSUs that vested were granted on 09/04/2024.